Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptides.
Kim BJ, Zhou J, Martin B, Carlson OD, Maudsley S, Greig NH, Mattson MP, Ladenheim EE, Wustner J, Turner A, Sadeghi H, Egan JM.
Kim BJ, et al. Among authors: martin b.
J Pharmacol Exp Ther. 2010 Sep 1;334(3):682-92. doi: 10.1124/jpet.110.166470. Epub 2010 May 24.
J Pharmacol Exp Ther. 2010.
PMID: 20498254
Free PMC article.